MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
2369 locations incl. Athens
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Spectrum Health - Helen DeVos Children's Hospital
Clinical research site in Grand Rapids, Michigan · 1840 WEALTHY ST SE, GRAND RAPIDS, MI 49506-2921 · (616) 774-7230
As of September 2026, 14 paid clinical trials are recruiting at Spectrum Health - Helen DeVos Children's Hospital in Grand Rapids, Michigan. Active studies at this site cover conditions such as Colorectal Cancer, Prostate Cancer and Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New trial at Spectrum Health - Helen DeVos Children's Hospital? We'll email you when one opens.
Recruiting clinical trials at Spectrum Health - Helen DeVos Children's Hospital (14)
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for Primary Generalized Tonic-Clonic Seizures
48 locations incl. Mobile
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 12+
Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
for Oligometastatic Prostate Cancer (OMPC)
37 locations incl. Fayetteville
Sponsor: Novartis Pharmaceuticals
Sex: Male·Age: 18 - 100
Code: NCT05939414·Phase 3·Recruiting·Listed Jul 2023
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for Prostate Cancer
27 locations incl. Birmingham
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male·Age: 18+
Code: NCT06056830·Phase 3·Recruiting·Listed Sep 2023
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for Urothelial Carcinoma Bladder
12 locations incl. Duarte
Sponsor: Aktis Oncology, Inc.
Sex: All·Age: 18+
Code: NCT07020117·Phase 1·Recruiting·Listed Jun 2025
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
for Neuroendocrine Tumors Unresectable
19 locations incl. Jacksonville
Sponsor: Perspective Therapeutics
Sex: All·Age: 18 - 90
Code: NCT05636618·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Pompe Pregnancy Sub-Registry
for Glycogen Storage Disease Type II (GSD-II)
14 locations incl. Phoenix
Sponsor: Genzyme, a Sanofi Company
Sex: Female·Age: All ages
Code: NCT00567073·Recruiting·Listed Dec 2007
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
for Down Syndrome
12 locations incl. Birmingham
Sponsor: Sequenom, Inc.
Sex: Female·Age: 18+
Code: NCT01429389·Recruiting·Listed Sep 2011
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
for Castration Resistant Metastatic Prostate Cancer
4 locations incl. Irvine
Sponsor: Aktis Oncology, Inc.
Sex: Male·Age: 18+
Code: NCT07581184·Phase 1·Recruiting·Listed May 2026
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
for Colorectal Cancer
1 location in Grand Rapids
Sponsor: GE Healthcare
Sex: All·Age: 18+
Code: NCT07219238·Phase 2, Phase 3·Recruiting·Listed Oct 2025
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
for Pancreatic Ductal Adenocarcinoma
9 locations incl. Birmingham
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT06562192·Phase 1·Recruiting·Listed Aug 2024
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for Prostatic Neoplasms, Castration-Resistant
7 locations incl. Stanford
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male·Age: 18+
Code: NCT04868604·Phase 1, Phase 2·Recruiting·Listed May 2021
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
for Castration-Resistant Prostate Cancer (CRPC)
4 locations incl. Dothan
Sponsor: Radiopharm Theranostics, Ltd
Sex: All·Age: 18+
Code: NCT07189871·Phase 1, Phase 2·Recruiting·Listed Sep 2025
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for Hematologic Malignancies
113 locations incl. Birmingham
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All·Age: All ages
Code: NCT01351545·Recruiting·Listed May 2011
Get new-trial alerts for Spectrum Health - Helen DeVos Children's Hospital
We'll email you whenever a new clinical trial starts recruiting at this research site in Grand Rapids, MI. Unsubscribe anytime.
More research sites in Grand Rapids
- START Midwest (63 trials)
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital (60 trials)
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital (51 trials)
- Corewell Health (39 trials)
- Trinity Health Grand Rapids Hospital (35 trials)
- Helen DeVos Children's Hospital (16 trials)
- BAMF Health (10 trials)
- Helen DeVos Children's Hospital at Spectrum Health (8 trials)
- Spectrum Health at Butterworth Campus (8 trials)
- Cancer and Hematology Centers of Western Michigan (8 trials)
Is this your research site?
This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.
Explore more
Paid clinical trials in Grand Rapids, MI · Michigan clinical trials